TOF treatment for early postoperative use of endothelin receptor antagonist for the BNP impact study
10.3760/cma.j.issn.1001-4497.2014.10.004
- VernacularTitle:法洛四联症矫治术后早期使用内皮素受体拮抗剂对B型利钠肽的影响
- Author:
Xiaoke SHANG
;
Gangcheng ZHANG
;
Mei LIU
;
Dalin CAI
;
Shanshan DING
;
Dingyang LI
- Publication Type:Journal Article
- Keywords:
Tetralogy of Fallot;
Endothelin receptor antagonist;
Endothelin-1;
Natriuretic peptide,brain
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2014;30(10):590-593
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the brain natriuretic peptide(BNP) levels and the effects of endothelin receptor antagonist(ERA) on BNP levels in patients with tetralogy of Fallot(TOF) recently surgical repaired.Methods During January 2010 to January 2012,32 cases of TOF after surgical repaired in hospital were selected.There are 20 males and 12 females,Aged 4 years to 18 years [mean age (7.64 ± 3.75) years] in age.All patients underwent enhanced CT to evaluate the pulmonary vessels and left ventricular before surgery arrangements.As the surgeries done,the patients were grouped randomly as either A or B.All 14 patients in group A started to follow the recommended dosage of bosentan within 3 days after surgery.Meanwhile,all 18 in group B had not taken bosentan or any other ERAs since the surgeries.Both group was evaluated and examined with echocardiography and blood test at the 10th day after surgery.Results None of the patients died within 10 days after surgery.BNP levels of group A was significantly lower than of group B.Inotropic score of group A was markedly lower,too.However,although group A showed mildly advantages in tricuspid regurgitation,pulmonary regurgitation,ratio of RV/LV end-systolic dimension and liver functions,there was no statistically significant difference.Conclusion For patients with tetralogy of Fallot,early use of ERAs after surgical repaired could reduce the use of inotropic agents and significantly decrease the BNP levels when discharged.
